Lan Huang
Chief Executive Officer at BEYONDSPRING INC.
Net worth: 27 M $ as of 2024-05-30
Profile
Lan Huang is the founder of Dalian Wanchun Biotechnology Co. Ltd.
(founded in 2010), Paramax International, Inc. (founded in 2008), BeyondSpring, Inc. (founded in 2013), and Wuxi Mtlh Biotechnology Co. Ltd.
(founded in 2007).
Dr. Huang is also the founder of Hubei Wanchun Biotechnology Co. Ltd., Seed Therapeutics, Inc., Seed Therapeutics, Inc. (Pennsylvania).
Dr. Huang's current job(s) include Chairman & Chief Executive Officer at BeyondSpring Pharmaceuticals, Inc. and Director at Sincere Efforts Foundation, Inc.Dr. Huang's former job(s) include Trustee at Lawrence University (2012-2015).
Dr. Huang's education history includes an undergraduate degree from Lawrence University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BEYONDSPRING INC.
26.16% | 2024-03-31 | 10,210,523 ( 26.16% ) | 27 M $ | 2024-05-30 |
Lan Huang active positions
| Companies | Position | Start |
|---|---|---|
| BEYONDSPRING INC. | Chief Executive Officer | 2014-10-31 |
Wuxi Mtlh Biotechnology Co. Ltd.
 Wuxi Mtlh Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Wuxi Mtlh Biotechnology Co. Ltd. is a private company based in Wuxi, China that develops anti-cancer drugs. The Chinese company was founded by Lan Huang and Lan Huang has been the CEO since incorporation. | Founder | 2006-12-31 |
BeyondSpring Pharmaceuticals, Inc.
 BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Chief Executive Officer | - |
| Seed Therapeutics, Inc.(Pennsylvania) | Chief Executive Officer | - |
| Seed Therapeutics, Inc. | Chief Executive Officer | - |
Former positions of Lan Huang
| Companies | Position | End |
|---|---|---|
| Lawrence University | Director/Board Member | 2014-12-31 |
| Dalian Wanchun Biotechnology Co. Ltd. | Founder | - |
Paramax International, Inc.
 Paramax International, Inc. Medical/Nursing ServicesHealth Services Part of ICON plc, Paramax International, Inc. is a Chinese company that provides clinical research services. The company is based in Beijing, China. The company was founded by Lan Huang. Paramax International was acquired by ReSearch Pharmaceutical Services LLC, part of ICON plc from August 21, 2013 on July 07, 2009 for $1.53 million. | Founder | - |
Training of Lan Huang
| Lawrence University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BEYONDSPRING INC. | Health Technology |
| Private companies | 6 |
|---|---|
Paramax International, Inc.
Paramax International, Inc. Medical/Nursing ServicesHealth Services Part of ICON plc, Paramax International, Inc. is a Chinese company that provides clinical research services. The company is based in Beijing, China. The company was founded by Lan Huang. Paramax International was acquired by ReSearch Pharmaceutical Services LLC, part of ICON plc from August 21, 2013 on July 07, 2009 for $1.53 million. | Health Services |
Wuxi Mtlh Biotechnology Co. Ltd.
Wuxi Mtlh Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Wuxi Mtlh Biotechnology Co. Ltd. is a private company based in Wuxi, China that develops anti-cancer drugs. The Chinese company was founded by Lan Huang and Lan Huang has been the CEO since incorporation. | Health Technology |
| Dalian Wanchun Biotechnology Co. Ltd. | |
BeyondSpring Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Health Technology |
| Seed Therapeutics, Inc.(Pennsylvania) | |
| Seed Therapeutics, Inc. |
- Stock Market
- Insiders
- Lan Huang
